Brief: Fate Therapeutics Posts Q2 Revenue Of $13.4 Mln
04/08/2021 22:34
Aug 4 (Reuters) - Fate Therapeutics Inc FATE.O :
* FATE THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
AND HIGHLIGHTS OPERATIONAL PROGRESS
* Q2 REVENUE $13.4 MILLION
* Q2 REVENUE ESTIMATE $6.3 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX36X1p3
Further company coverage: FATE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fate Therapeutics
See all newsBrief: Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial Of FT819 For The Treatment Of Lupus Nephritis
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Q2 loss narrows as expenses fall, revenue rises
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview